Related Experiment Video
Updated: Sep 1, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
CD40/TRAF1 decreases synovial cell apoptosis in patients with rheumatoid arthritis through JNK/NF-κB pathway
Tao Cheng1, Jian Wu2, Yaozeng Xu3
1Department of Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China. chengtao0526@126.com.
Introduction:
A genome-wide association analysis revealed a rheumatoid arthritis (RA)-risk-associated genetic locus on chromosome 9, which contained the tumor necrosis factor receptor-associated factor 1 (TRAF1). However, the detail mechanism by TRAF1 signaled to fibroblast-like synoviocytes (FLSs) apoptosis remains to be fully understood.
Materials And Methods:
Synovial tissue of 10 RA patients and osteoarthritis patients were obtained during joint replacement surgery. We investigated TRAF1 level and FLSs apoptosis percentage in vivo and elucidated the mechanism involved in the regulation of apoptotic process in vitro.
Results:
We proved the significant increase of TRAF1 level in FLSs of RA patients and demonstrated that TRAF1 level correlated positively with DAS28 score and negatively with FLSs apoptosis. Treatment with siTRAF1 was able to decrease MMPs levels and the phosphorylated forms of JNK/NF-κB in vitro. Moreover, JNK inhibitor could attenuate expression of MMPs and increase percentage of apoptosis in RA-FLSs, while siTRAF1 could not promote apoptosis when RA-FLSs were pretreated with JNK activator.
Conclusions:
High levels of TRAF1 in RA synovium play an important role in the synovial hyperplasia of RA by suppressing apoptosis through activating JNK/NF-kB-dependent signaling pathways in response to the engagement of CD40.
Insights
High tumor necrosis factor receptor-associated factor 1 (TRAF1) levels in rheumatoid arthritis (RA) synovium suppress fibroblast-like synoviocytes (FLSs) apoptosis. This process involves activating JNK/NF-κB signaling pathways, contributing to synovial hyperplasia in RA.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Rheumatoid arthritis (RA) risk is linked to a genetic locus on chromosome 9 containing the tumor necrosis factor receptor-associated factor 1 (TRAF1) gene.
- The precise mechanisms by which TRAF1 influences apoptosis in fibroblast-like synoviocytes (FLSs) in RA remain unclear.
Purpose of the Study:
- To investigate the role of TRAF1 in RA pathogenesis.
- To elucidate the signaling pathways through which TRAF1 affects FLS apoptosis.
Main Methods:
- Analysis of TRAF1 levels and FLS apoptosis in synovial tissues from RA and osteoarthritis patients.
- In vitro experiments using small interfering RNA (siRNA) targeting TRAF1 and JNK inhibitors in RA-FLSs.
Main Results:
- TRAF1 levels were significantly increased in RA FLSs and correlated positively with disease activity (DAS28 score) and negatively with FLS apoptosis.
- Reducing TRAF1 levels decreased matrix metalloproteinases (MMPs) and phosphorylated JNK/NF-κB.
- JNK inhibition increased apoptosis and decreased MMPs, while TRAF1 knockdown failed to induce apoptosis in the presence of JNK activators.
Conclusions:
- Elevated TRAF1 in RA synovium promotes synovial hyperplasia by inhibiting FLS apoptosis.
- This inhibition occurs via the activation of JNK/NF-κB signaling pathways, particularly in response to CD40 engagement.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway

